Catalyst OrthoScience Inc., headquartered in the United States, is a pioneering company in the orthopaedic industry, specialising in innovative solutions for joint reconstruction and repair. Founded in 2013, the company has rapidly established itself as a leader in the development of advanced orthopaedic technologies, particularly its unique Catalyst® System, which enhances surgical precision and patient outcomes. With a focus on minimally invasive procedures, Catalyst OrthoScience is committed to improving the quality of life for patients suffering from musculoskeletal conditions. The company operates primarily in the US market, with aspirations for global expansion. Notable achievements include securing key partnerships and receiving recognition for its cutting-edge products, positioning Catalyst OrthoScience as a formidable player in the orthopaedic landscape.
How does Catalyst OrthoScience Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Catalyst OrthoScience Inc.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Catalyst OrthoScience Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that Catalyst OrthoScience may not yet have established a comprehensive climate strategy or may be in the early stages of developing one. In the context of the industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific emissions data or commitments, it is challenging to assess Catalyst OrthoScience's position relative to its peers in the orthopaedic sector. As the company progresses, it may consider aligning with industry standards and frameworks to enhance its climate commitments and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Catalyst OrthoScience Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
